Clinical Trial Update: Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating cholecalciferol (25-[OH]-Vitamin D) for colorectal cancer was withdrawn and did not proceed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Mucinous Adenocarcinoma of the Colon
• Mucinous Adenocarcinoma of the Rectum
• Rectal Cancer
• Signet Ring Adenocarcinoma of the Colon
• Signet Ring Adenocarcinoma of the Rectum

Drugs mentioned

• Cholecalciferol (Vitamin D3)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum | EARLY_Phase 1 | Status: WITHDRAWN